Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas.
May 6th, 2008 by 
admin (Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)
Posted in Cancer | 
May 6th, 2008 by admin Related posts